INSIGHTS ON SOLID DOSE MANUFACTURING

• Engineering Challenges Of Designing Pharmaceutical Isolators

  Designing pharmaceutical isolators requires navigating complex engineering hurdles, from ensuring chemical compatibility to optimizing airflow and pressure. Explore the critical considerations that guarantee drug manufacturing safety and efficiency.

• Spray Dry Biologics For Oral Dosage Forms

  Spray drying enables stable oral delivery of biologics by creating protective dry powders, improving bioavailability, stability, and targeted release compared with traditional formulation methods.

• HPAPIS Production: "Where Micrograms Matters"

  In HPAPI manufacturing, micrograms make a difference. Risk‑based containment, smart facility design, and exposure limits safeguard people, product, and performance.

• How To Achieve Late-Phase Success In Complex OSD Development

  Late-phase OSD scale-up demands more than technical know-how. This paper examines the frameworks, tools, and partnership models that determine whether promising molecules reach commercial production reliably.

• Exploring The Need For Dose-Flexible Manufacturing

  9/9/2026

  Regulatory pressure to study broader dose ranges is reshaping formulation strategy. This executive summary examines how early planning for dose flexibility reduces development risk and clinical delays.

• Developing And Manufacturing Drugs With HPAPIs

  1/27/2025

  Learn why companies must invest in specialized expertise to develop scalable, safe, and efficient manufacturing processes for highly potent oral solid dose products.

• Solubility Enhancement Via Amorphous Solid Dispersions

  2/27/2025

  Polyvinyl alcohol (PVA) is a versatile polymer platform used to enhance solubility through hot melt extrusion. Explore the role it plays in drug solubility, hydrolysis, and thermal behaviors.

• Overcoming The Obstacles Of Spray-Dried Dispersion Scale-Up

  9/9/2026

  SDD scale-up introduces scale-dependent risks that threaten bioavailability, stability, and manufacturability. This white paper details a model-based framework for managing those risks from early feasibility through commercial production.

• Overview Of Hot Melt Extrusion And Its Pharmaceutical Applications

  8/31/2026

  More than 40% of NCEs face aqueous solubility challenges. Here, we examine how hot melt extrusion addresses solubility, modified release, abuse deterrence, and scale-up across pharmaceutical development.